GNI Group Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY18.51 |
Market Cap |
JPY53.45 B |
Shares Outstanding |
13.9 M |
Public Float |
13.01 M |
Address |
Nihonbashi Honcho YS Bldg., 3/F Tokyo Tokyo 103 Japan |
Employees | - |
Website | http://www.gnipharma.com |
Updated | 07/08/2019 |
GNI Group Ltd. engages in the development, research, manufacture, and sales of pharmaceutical drugs and traditional Chinese medicines. It operates through Japan and China segments. The Japan segment deals with licensing, preclinical studies, clinical trials, and sales. |